Barofsky I - Search Results

1

A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.

Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I, Rosenberg SA. Chang AE, et al. Among authors: barofsky i. Cancer. 1981 Apr 1;47(7):1746-51. doi: 10.1002/1097-0142(19810401)47:7<1746::aid-cncr2820470704>3.0.co;2-4. Cancer. 1981. PMID: 6261926 Clinical Trial.

2

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.

Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky I, Simon RM, Rosenberg SA. Chang AE, et al. Among authors: barofsky i. Ann Intern Med. 1979 Dec;91(6):819-24. doi: 10.7326/0003-4819-91-6-819. Ann Intern Med. 1979. PMID: 293141 Clinical Trial.

3

Quality of life assessment of patients in extremity sarcoma clinical trials.

Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ. Sugarbaker PH, et al. Among authors: barofsky i. Surgery. 1982 Jan;91(1):17-23. Surgery. 1982. PMID: 7054901 Clinical Trial.

4

5-Fluorouracil chemotherapy and pelvic radiation in the treatment of large bowel cancer. Decreased toxicity in combined treatment with 5-fluorouracil administration through the intraperitoneal route.

Sugarbaker PH, Gianola FJ, Barofsky I, Hancock SL, Wesley R. Sugarbaker PH, et al. Among authors: barofsky i. Cancer. 1986 Aug 15;58(4):826-31. doi: 10.1002/1097-0142(19860815)58:4<826::aid-cncr2820580403>3.0.co;2-o. Cancer. 1986. PMID: 3521842 Clinical Trial.

5

Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.

Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Sugarbaker PH, et al. Among authors: barofsky i. Surgery. 1985 Sep;98(3):414-22. Surgery. 1985. PMID: 3898450 Clinical Trial.

6

Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.

Gianola FJ, Sugarbaker PH, Barofsky I, White DE, Meyers CE. Gianola FJ, et al. Among authors: barofsky i. Am J Clin Oncol. 1986 Oct;9(5):403-10. doi: 10.1097/00000421-198610000-00009. Am J Clin Oncol. 1986. PMID: 3776903 Clinical Trial.

7

Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.

Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE. Sugarbaker PH, et al. Among authors: barofsky i. Semin Oncol. 1985 Sep;12(3 Suppl 4):101-11. Semin Oncol. 1985. PMID: 3901269 Clinical Trial.

8

Health-related quality of life: methods of assessment.

Barofsky I. Barofsky I. Horm Res. 2001;56 Suppl 1:51-4. doi: 10.1159/000048135. Horm Res. 2001. PMID: 11786686 Review.

9

Pain in the obese: impact on health-related quality-of-life.

Barofsky I, Fontaine KR, Cheskin LJ. Barofsky I, et al. Ann Behav Med. 1997 Fall;19(4):408-10. doi: 10.1007/BF02895160. Ann Behav Med. 1997. PMID: 9706368

10

Can quality or quality-of-life be defined?

Barofsky I. Barofsky I. Qual Life Res. 2012 May;21(4):625-31. doi: 10.1007/s11136-011-9961-0. Epub 2011 Jul 3. Qual Life Res. 2012. PMID: 21725867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page